4 July 2018
Seventure Partners invests in IZICAP
IZICAP is the creator of a SaaS platform to collect, analyze and monetize payment data for local stores.
All
12 June 2018
INTENTO DESIGN cooperates with STMICROELECTRONICS to accelerate analog design and migration of FD-SOI chips at functional level
Intento Design has announced its collaboration with STMicroelectronics (ST) in pushing forward its ID-XploreTM EDA software aimed to solve the critical design challenges in the...
30 April 2018
Seventure Partners invests in A-Mansia
A-Mansia Biotech S.A., a belgian microbiome company, announces a €13 million first close of its Series A financing, led by Seventure Partners.
12 April 2018
The LiMAx® liver capacity test is now commercially available in Germany, Austria and the UK
Humedics GmbH, a specialist in real-time measurement of individual liver function, today announced that the company has received Marketing Authorization for its diagnostic...
21 March 2018
Adisseo and Seventure Partners announce €24m First Close of AVF, a New Fund Dedicated to Innovative Animal Health and Nutrition
Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in Life science microbiome investment, today announces that it has launched AVF, the...
8 March 2018
MaaT Pharma Launches European Clinical Trial in Severe Acute Graft-versus-Host Disease for patients receiving allogeneic Hematopoietic Stem Cell Transplantation
MaaT Pharma, a clinical-stage biopharmaceutical company, received authorization from competent authorities to launch its phase II prospective multicenter clinical trial in...
31 January 2018
Seventure Partners announces that BPCE invests in its institutional funds, DIGITAL OPPORTUNITIES FUND
Paris, 31st January 2018 – Seventure Partners, a leading European player in innovation financing and affiliate of Natixis Investment Managers, announces today the second...
18 January 2018
Seventure Partners Life Sciences Investing Update – H2 2017
“2017 ended on a high note. Our Health For Life Capital™ investment vehicle has backed some truly remarkable disruptive technologies over the second half of the year and...
4 January 2018
Zipongo extends total financing to over $50M to launch FoodScripts™ and lower chronic disease costs
Zipongo plans to use the additional funding to expand its nutrition platform beyond wellness to use food as first-line therapy in treating chronic disease.
7 December 2017
Vedanta Biosciences announces initiation of Phase 1a/1b trial for new drug class of rationally-defined bacteria consortia derived from the human microbiome
VE303 is first known rationally-defined bacterial consortium in powder form to enter the clinic and has recieved Orphan Drug designation from the US FDA for C. difficile...